Company Overview
American Health Care Capital is proud to exclusively present a well-established Diabetic Supply Company located in the Southwest, specializing in CGM and Diabetic Supplies Founded in 2015, the company has experienced consistent, year-over-year growth and has become a respected leader in the direct-to-patient medical supply industry.
The company is licensed by Medicare (CMS) and accredited by the Board of Certification (BOC), with a payer mix of 80% Medicare and 20% private insurance. It operates under strict HIPAA compliance, ensuring the highest standards of privacy and quality in every aspect of patient care and service delivery.
Growth Opportunities
The true value of this business lies in its over 5,000 CGM clients, a number that continues to grow steadily each week. A Strategic buyer will add 5,000 new CGM clients to their existing business at closing.
With a strong emphasis on direct-to-consumer services, the company has refined its shipping model to be cost-effective, dependable, and user-friendly. Customers benefit from timely home delivery, simplified product codes, and color-coded labeling, enabling quick and efficient inventory tracking. These features save valuable time for caregivers, allowing them to focus on providing high-quality clinical care.
Staff Overview
The organization is staffed by a team of experienced professionals dedicated to compassionate, patient-centered care. Services emphasize preventive care, diagnosis, and treatment, with the overarching goal of improving the health and quality of life for the patients and communities it serves. The company also supports caregivers and practitioners through its customer-focused solutions, including offerings tailored to the dialysis segment, helping providers meet and maintain lofty standards of care.
Over the years, the business has built a loyal and growing customer base. One of its most significant assets is its rapidly expanding Continuous Glucose Monitoring (CGM) program, which currently serves over 5,000 active clients, with new enrollments occurring weekly. This core CGM client base represents a key value driver for a strategic buyer.
Financial Overview
The company is recession-resistant and presents substantial growth opportunities, particularly with expansion into the East Coast and Southeast regions, where demand for its services is expected to be strong. A strategic buyer with additional sales and marketing resources could significantly accelerate top-line revenue growth.
The current owner is committed to supporting a smooth transition and is willing to remain with the business for up to one-year post-sale, making this an ideal acquisition for a strategic buyer seeking to expand in the healthcare supply space.
In 2024 Gross Revenue was $18.06 Million with EBITDA of $565,000. In 2025 They are on track for $17 Million with EBITDA in the $700,000 range.
Asking Price
The asking price is To Be Determined. This excludes working capital and accounts receivable.
